Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN, Ireland and CHICAGO, Jan. 11, 2023 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (“Iterum Therapeutics”), a clinical-stage pharmaceutical…
NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset…
CHASKA, Minn., Jan. 11, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), announced today that it received…
Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital ManagementDUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 11,…
ROCKVILLE, Md., Jan. 11, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company…
LA JOLLA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
LA JOLLA, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE:PSYG | OTCQB: PSYGF), a life science biotechnology…
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered…
Reaffirms Full-Year 2022 Revenue GuidanceMORRISVILLE, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq: SYNH), the only fully integrated…